Verve Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	350,023	345,436	232,215	176,049	962,726	1,017,156	Upgrade
Market Cap Growth	65.57%	48.76%	31.90%	-81.71%	-5.35%	300.08%	Upgrade
Enterprise Value	324,532	312,673	187,194	118,393	878,582	964,687	Upgrade
Last Close Price	2330.00	2220.00	1292.00	937.19	5410.00	7013.09	Upgrade
PS Ratio	3.74	3.72	3.31	2.36	16.52	29.02	Upgrade
PB Ratio	2.14	2.08	1.41	0.86	4.26	6.05	Upgrade
P/TBV Ratio	6.72	6.71	3.32	2.04	9.95	17.68	Upgrade
P/FCF Ratio	-	23.37	34.05	-	-	7463.50	Upgrade
P/OCF Ratio	-	23.15	33.12	-	-	1565.43	Upgrade
EV/Sales Ratio	3.74	3.37	2.67	1.59	15.08	27.52	Upgrade
EV/EBITDA Ratio	131.92	90.64	-	-	-	-	Upgrade
EV/FCF Ratio	22.34	21.16	27.45	-	-	7078.50	Upgrade
Debt / Equity Ratio	0.14	0.14	0.12	0.12	0.12	0.07	Upgrade
Debt / EBITDA Ratio	4.82	5.52	-	-	-	-	Upgrade
Debt / FCF Ratio	1.55	1.57	2.87	-	-	88.66	Upgrade
Asset Turnover	0.43	0.42	0.34	0.30	0.25	0.24	Upgrade
Quick Ratio	4.17	3.63	6.20	5.82	8.17	7.34	Upgrade
Current Ratio	4.78	4.20	6.64	6.17	8.43	7.52	Upgrade
Return on Equity (ROE)	-0.39%	-1.24%	-10.01%	-11.64%	-9.75%	-7.71%	Upgrade
Return on Assets (ROA)	0.15%	-0.24%	-1.99%	-5.03%	-5.05%	-4.02%	Upgrade
Return on Capital (ROIC)	0.17%	-0.25%	-2.12%	-5.33%	-5.31%	-4.21%	Upgrade
Earnings Yield	-0.20%	-0.66%	-7.39%	-13.92%	-2.02%	-0.96%	Upgrade
FCF Yield	4.15%	4.28%	2.94%	-3.20%	-0.22%	0.01%	Upgrade
Buyback Yield / Dilution	12.63%	9.49%	-0.18%	-5.06%	-18.73%	-12.78%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.